Lobe Sciences (XCNQ:LOBE) EBIT per Share : C$-0.01 (TTM As of Feb. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences EBIT per Share?

Lobe Sciences's EBIT per Share for the three months ended in Feb. 2024 was C$-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 47.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 30.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Lobe Sciences's EBIT per Share or its related term are showing as below:

XCNQ:LOBE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -76 Med: 20.95 Max: 49.1
Current: 47.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Lobe Sciences was 49.10% per year. The lowest was -76.00% per year. And the median was 20.95% per year.

XCNQ:LOBE's 3-Year EBIT Growth Rate is ranked better than
92.56% of 1304 companies
in the Biotechnology industry
Industry Median: 3.6 vs XCNQ:LOBE: 47.10

Lobe Sciences's EBIT for the three months ended in Feb. 2024 was C$-0.57 Mil.

Lobe Sciences EBIT per Share Historical Data

The historical data trend for Lobe Sciences's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EBIT per Share Chart

Lobe Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

EBIT per Share

Get a 7-Day Free Trial

-0.10

-0.22

-0.20

-0.32

-0.04

Lobe Sciences Quarterly Data
	Dec18	Mar19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	Aug23	Nov23	Feb24
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.01	-	-0.01	-0.01

Lobe Sciences EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Lobe Sciences's EBIT per Share for the fiscal year that ended in Aug. 2023 is calculated as

	EBIT per Share		(A: Aug. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.464	/	104.351
=	-0.04

Lobe Sciences's EBIT per Share for the quarter that ended in Feb. 2024 is calculated as

	EBIT per Share		(Q: Feb. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.573	/	79.136
=	-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01

Lobe Sciences (XCNQ:LOBE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Lobe Sciences EBIT per Share Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences (XCNQ:LOBE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines